treosulfan has been researched along with Brain Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamberg, M; Dichgans, J; Duffner, F; Hermisson, M; Kortmann, RD; Küker, WM; Weller, M; Wick, W | 1 |
| Baumgart, J; Dichgans, J; Klockgether, T; Reber, U; Seyfried, J; Trepel, M; Weller, M; Wüllner, U | 1 |
| Dichgans, J; Herrlinger, U; Schmidt, F; Weller, M; Wick, W | 1 |
| Baumgart, J; Seyfried, J; Stock, J; Weller, M; Wick, W; Wüllner, U | 1 |
2 trial(s) available for treosulfan and Brain Neoplasms
| Article | Year |
|---|---|
Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Brain Neoplasms; Busulfan; Deoxycytidine; Disease-Free Survival; Drug Therapy, Combination; Female; Gemcitabine; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Neoadjuvant Therapy; Venous Thrombosis | 2002 |
Treosulfan chemotherapy for recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Bone Marrow; Brain Neoplasms; Busulfan; Cohort Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Salvage Therapy; Survival Analysis; Treatment Outcome | 2000 |
2 other study(ies) available for treosulfan and Brain Neoplasms
| Article | Year |
|---|---|
Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Busulfan; Buthionine Sulfoximine; Drug Synergism; Gene Transfer Techniques; Glioma; Glutathione; Humans; Prohibitins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1998 |
CD95/CD95 ligand-independent potentiation of treosulfan cytotoxicity by BSO in malignant glioma cells in vitro and in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Apoptosis; Blood Cell Count; Brain Neoplasms; Busulfan; Buthionine Sulfoximine; Cell Division; Drug Synergism; Fas Ligand Protein; fas Receptor; Gene Transfer Techniques; Glioma; Glutathione; Humans; In Vitro Techniques; Ligands; Membrane Glycoproteins; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |